Protective role of metallothionein in stress-induced gastric ulcer in rats

Table 1 The content of MT, CD and MDA in rat plasma, stomach and liver (mean±SD).

	Control	WIR	ZnSO4	WIR+ ZnSO4	WIR+MT
CD content in plasma (A/mL)	10.19±1.81	37.37±2.04b	10.33±2.07a	19.08±1.52ab	18.64±1.32ab
CD content in stomach (A/g tissue)	39.96±6.74	73.09±3.71b	51.39±4.41ab	60.48±3.93ab	62.43±4.99ab
CD content in liver (A/g tissue)	64.87±3.05	83.26±3.78b	66.99±4.7a	68.07±4.93a	80.76±3.16b
MDA content in plasma (nmol/mL)	3.65±0.41	4.88±0.30b	3.98±0.35a	4.20±0.21a	4.77±0.18b
MDA content in stomach (nmol/g tissue)	4.17±0.18	5.06±0.77	4.67±0.54	4.21±0.62	4.01±0.32a
MDA content in liver (nmol/g tissue)	6.86±0.86	8.87±1.20b	7.27±0.57a	6.60±0.87a	7.21±0.44a
MT content in stomach (mg/g protein)	1.080±0.066	1.875±0.285c	1.925±0.7ce	1.813±0.448ce	1.493±0.188c
MT content in liver (mg/g protein)	9.955±1.358	28.325±7.117	54.165±19.224ce	56.63±15.218ce	12.575±6.106c

n = 6 in each group.

^aP<0.05 vs stress group,

^bP<0.01 vs control group,

^cP<0.05 vs control,

^eP<0.05 vs stress group, respectively.